default author photo

Lihui Wei

Peking University - Department of Obstetrics and Gynecology

Beijing

China

SCHOLARLY PAPERS

3

DOWNLOADS

170

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Genotype Distribution and Prevalence of High-Risk Human Papillomavirus Based on 20,103 Self-Collected Samples From 13 Regions of China

Number of pages: 22 Posted: 10 Nov 2021
Peking University - Department of Obstetrics and Gynecology, Peking University - Department of Obstetrics and Gynecology, Jiangxi Maternal and Child Health Hospital - Department of Obstetrics and Gynecology, Maternal and Children Health Hospital of Guangxi Zhuang Autonomous Region - Department of Obstetrics and Gynecology, Guizhou Provincial People's Hospital - Department of Obstetrics and Gynecology, Kunming City Maternal and Child Health Hospital, XinJiang Changji Maternal and Child Health and Family Planning Service Center - Department of Women’s Health Care, Xining First People's Hospital, Zhejiang University - Department of Obstetrics and Gynecology, Jilin University (JLU) - Department of Obstetrics and Gynecology, China Medical University - Department of Obstetrics and Gynecology, Xi'an Jiaotong University (XJTU) - Department of Obstetrics and Gynecology, Maternal and Child Health and Family Planning Service Center of Zhengxiangbaiqi - Department of Obstetrics and Gynecology, Peking University - Department of Obstetrics and Gynecology, Peking University - Department of Obstetrics and Gynecology, Peking University - Department of Obstetrics and Gynecology, Peking University - Department of Obstetrics and Gynecology, Peking University - Department of Obstetrics and Gynecology and Peking University - Department of Obstetrics and Gynecology
Downloads 58 (980,173)

Abstract:

Loading...

cervical cancer screening;high-risk human papillomavirus;self-sampling;genotype distribution;epidemiological characteristics

2.

Management of Cervical Cancer in Pregnant Women: A Multi-Center Retrospective Study in China

Number of pages: 16 Posted: 08 Oct 2018
Peking University, Peking University, Sichuan University, Shandong University, Jiangxi Maternal and Child Health Hospital, China Medical University, Zhengzhou University - Department of Gynecology, Nanjing Medical University - Nanjing Medical Hospital, Xi'an Jiaotong University (XJTU), Capital Medical University - Beijing Chaoyang Hospital, Guizhou Provincial People's Hospital, Peking University, Nanjing University - The Affiliated Drum Tower Hospital, Chongqing Medical University, Hainan Provincial People's Hospital, Fudan University - Department of Obstetrics and Gynecology, Chongqing Tumor Research Institute, Beijing Tsinghua Changgeng Hospital, Peking University, Peking University, Peking University - Department of Obstetrics and Gynecology and Peking University - Department of Obstetrics and Gynecology
Downloads 57 (989,921)

Abstract:

Loading...

cervical cancer, pregnancy, treatment;neoadjuvant chemotherapy

3.

Naturally Acquired Antibodies Against Human Papillomavirus are Protective Against Subsequent Homotypic Infection: A Large-Scale Prospective Cohort Study

Number of pages: 58 Posted: 16 Feb 2021
Xiamen University, Chinese Academy of Medical Sciences - Department of Cancer Epidemiology, Peking University People's Hospital, Peking University - Department of Obstetrics and Gynecology, Jiangsu Provincial Center for Disease Control and Prevention, Peking University People's Hospital, Xiamen Innovax Biotech Company, Xiamen Innovax Biotech Company, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Nanjing University - The Affiliated Drum Tower Hospital, Shenzhen Maternity and Child Healthcare Hospital, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chinese Academy of Medical Sciences - National Cancer Center, Peking University, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Xiamen University, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen University, Chinese Academy of Medical Sciences - National Cancer Center, Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen Innovax Biotech Company, Chinese Academy of Medical Sciences - National Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - School of Population Medicine and Public Health, Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics and Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics
Downloads 55 (1,010,164)

Abstract:

Loading...